Correction to: Nature Communications https://doi.org/10.1038/s41467-018-04120-z, published online 3 May 2018.

In the original version of the Article, the authors stated they had no competing interests to declare. They omitted to declare that Dr. Ye is a shareholder of Wuhan Yuanzheng Pharmaceuticals Inc. and Shanghai Braegen Pharmaceuticals Inc. This has now been corrected in the PDF and HTML versions of the article.